Raf Hofstein
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
Raphael Hofstein is the founder of Israel Tech Transfer Organization.
Dr. Hofstein is currently Chief Executive Officer & Director at Triphase Accelerator Corp., Chairman at Clinical Trials Ontario, Encycle Therapeutics, Inc., and Notch Therapeutics, Inc. Dr. Hofstein is an Independent Director at BioLineRx Ltd. since 2003, Director at Cell Cure Neurosciences Ltd., Life Sciences Ontario, Dynamic Memory Medical Technologies Ltd., Terheuer Ltd., Bedside Clinical Systems, Inc., Accel-Rx, and Director at Scopus Biopharma, Inc. since 2022.
Formerly, Dr. Hofstein was Chairman, President & Chief Executive Officer at Hadasit Medical Research Services & Development Ltd. from 2000 to 2009, President, Chief Executive Officer & Director at Toronto Innovation Acceleration Partners from 2009 to 2020, President & Chief Executive Officer at Xagenic, Inc., Chairman at Fibrocor Therapeutics, Inc., Co-Chairman at LifeBond Ltd., Chairman at HBL- Hadasit Bio-Holdings Ltd. in 2005, Chairman of the Board at Hadasit Bio-Holdings Ltd. from 2010 to 2015, Chairman at KAHR Medical Ltd., Director-Business Unit at Ecogen, Inc., Director at Forticell Bioscience, Inc. from 2006 to 2008, Director at ConjuGate Ltd., Director at Evogene Ltd. from 2000 to 2012, Director at Thrombotech Ltd., TK-Signal Ltd., ProtAb Ltd., Verto Medical Ltd., Bio-MarCare Technologies Ltd., Centre For Commercialization of Regenerative Medicine, G.V.T Ltd., QD Solar, Inc., Independent Director at Scopus Biopharma, Inc. from 2020 to 2022, President at Mindsense Biosystems Ltd., and Manager-Research & Development at International Genetic Science Partnership.
Education includes undergraduate degree from The Hebrew University of Jerusalem in 1974, graduate degree from Weizmann Institute of Science in 1975, and doctorate from Weizmann Institute of Science in 1980.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOLINERX LTD. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOLINERX LTD. | Director/Board Member | 01/01/2003 |
| SCOPUS BIOPHARMA INC. | Director/Board Member | 28/04/2022 |
Dynamic Memory Medical Technologies Ltd. | Director/Board Member | - |
Terheuer Ltd. | Director/Board Member | - |
Life Sciences Ontario
Life Sciences Ontario Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that advancing life sciences through advocacy, policy work, educational and networking events & support services | Director/Board Member | - |
Clinical Trials Ontario
Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Operates charitable organization to promote clinical research | Chairman | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Director/Board Member | - |
Encycle Therapeutics, Inc.
Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Chairman | - |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Provides investment services | Director/Board Member | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 37 |
|---|---|
Ecogen, Inc. /Old/
Ecogen, Inc. /Old/ Chemicals: AgriculturalProcess Industries Develops and markets environmentally compatible products | Process Industries |
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Advances regenerative medicine through development of cellular technology & advanced biomaterial products | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
LifeBond Ltd.
LifeBond Ltd. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for bio-surgery and tissue repair | Health Technology |
ConjuGate Ltd.
ConjuGate Ltd. Medical/Nursing ServicesHealth Services Develops a novel antifungal therapy for systemic treatment | Health Services |
Evogene Ltd.
Evogene Ltd. BiotechnologyHealth Technology Operates as computational biology company, which focuses on product discovery and development | Health Technology |
HBL- Hadasit Bio-Holdings Ltd.
HBL- Hadasit Bio-Holdings Ltd. Investment ManagersFinance Provides investment services in research and development companies for the medical & biotechnology sectors | Finance |
Hadasit Bio-Holdings Ltd. /Private Equity/
Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings /Private Equity/ invests in both public and private companies located in Israel. The firm focuses on biotechnology sectors such as immuno-oncology, ophthalmology, and inflammatory diseases. It participates in buyout transactions. The firm acquires minority interests. | Finance |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Develops drugs that prevent and treat acute thromboembolic events | Health Technology |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Develops cell therapies for neural degenerative diseases | Health Technology |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology Develops therapies for hematological cancer applications | Health Technology |
ProtAb Ltd.
ProtAb Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents that modulate cytokine regulation and tipping the balance toward anti-inflammatory signaling pathways | Health Technology |
Verto Medical Ltd.
Verto Medical Ltd. BiotechnologyHealth Technology Develops disease-specific treatment for systemic lupus erythematosus | Health Technology |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Operates as a commercialization agent | Health Technology |
Mindsense Biosystems Ltd. | |
Bio-MarCare Technologies Ltd.
Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance | Health Services |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories | Health Technology |
Life Sciences Ontario
Life Sciences Ontario Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that advancing life sciences through advocacy, policy work, educational and networking events & support services | Commercial Services |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Provides regenerative medicine-based technologies and cell and gene therapy | Health Technology |
Dynamic Memory Medical Technologies Ltd. | |
G.V.T Ltd.
G.V.T Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Terheuer Ltd. | |
Bedside Clinical Systems, Inc.
Bedside Clinical Systems, Inc. Packaged SoftwareTechnology Services Provides workflow integrated decision-support software to healthcare industry | Technology Services |
Clinical Trials Ontario
Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Operates charitable organization to promote clinical research | Commercial Services |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Provides investment services | Finance |
Encycle Therapeutics, Inc.
Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Health Technology |
QD Solar, Inc.
QD Solar, Inc. SemiconductorsElectronic Technology Develops stable multilayered perovskite-based photovoltaic materials | Electronic Technology |
Israel Tech Transfer Organization
Israel Tech Transfer Organization Miscellaneous Commercial ServicesCommercial Services Operates as a technology transfer company | Commercial Services |
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP BiotechnologyHealth Technology Develops tissue-specific therapeutics for fibrotic diseases | Health Technology |
Scopus Biopharma, Inc.
Scopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company develops transformational therapeutics for serious diseases | Health Technology |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Health Technology |
International Genetic Science Partnership |
Select your edition
All financial news and data tailored to specific country editions